ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,433.74
      0.23%
      US Tech 100
      19,100.80
      0.17%
      Dow Jones
      38,647.10
      -0.17%
      Brent Oil
      82.365
      0.48%
      Bitcoin
      66,954.89
      0.30%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Stoke Therapeutics Inc (STOK)

      7. Stoke Therapeutics Inc (STOK) News

      STOK

      Stoke Therapeutics (STOK)

      Stoke Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:STOK
      DateTimeSourceHeadlineSymbolCompany
      06/13/20244:06PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STOKStoke Therapeutics Inc
      06/07/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/07/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/07/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/07/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/07/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/06/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STOKStoke Therapeutics Inc
      06/05/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      06/03/20244:30PMBusiness WireStoke Therapeutics to Present at Upcoming Investor Conferences in JuneNASDAQ:STOKStoke Therapeutics Inc
      05/22/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/22/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/20/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/20/20244:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/17/20244:30PMBusiness WireStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:STOKStoke Therapeutics Inc
      05/17/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/17/20244:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      05/06/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STOKStoke Therapeutics Inc
      05/06/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STOKStoke Therapeutics Inc
      05/06/20247:00AMBusiness WireStoke Therapeutics Reports First Quarter Financial Results and Provides Business UpdatesNASDAQ:STOKStoke Therapeutics Inc
      04/29/20248:00AMBusiness WireStoke Therapeutics Appoints Thomas Leggett as Chief Financial OfficerNASDAQ:STOKStoke Therapeutics Inc
      04/17/20248:00AMBusiness WireStoke Therapeutics Appoints Jason Hoitt as Chief Commercial OfficerNASDAQ:STOKStoke Therapeutics Inc
      04/04/20244:30PMBusiness WireStoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STOKStoke Therapeutics Inc
      03/27/202411:40PMBusiness WireStoke Therapeutics Announces Pricing of Upsized $125 Million Public OfferingNASDAQ:STOKStoke Therapeutics Inc
      03/26/20244:07PMBusiness WireStoke Therapeutics Announces Proposed Public OfferingNASDAQ:STOKStoke Therapeutics Inc
      03/25/20244:01PMBusiness WireStoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:STOKStoke Therapeutics Inc
      03/25/20244:01PMBusiness WireStoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet SyndromeNASDAQ:STOKStoke Therapeutics Inc
      03/05/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
      03/01/20244:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
      02/26/202410:38AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STOKStoke Therapeutics Inc
      02/26/202410:36AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:STOKStoke Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:STOK